Destiny Pharma Share Discussion Threads

[rafboy] 03/2/2021 21:14

Nice to hear Nobby. I was unable to listen in but hopefully it will be available later.

[nobbygnome] 03/2/2021 19:47

Just listening to the Shares’ presentation and I am very impressed! I am not quite sure how I haven’t heard them present before. I took a small stake today but will be looking to buy more.

[mach100] 03/2/2021 12:07

Or Malcolm how about posting on DEST threads about Destiny and perhaps about Open Orphan on ORPH thread? Just a thought of mine instead of hawking DEST elsewhere. I come here to read about DEST and don't need information about other companies here. Revolutionary?

[okidokicoki] 03/2/2021 11:33

I would be straight back on that chat malcome :-) just to rub it in :-)

[malcolmmm] 03/2/2021 11:20

recommended these at 62p on the ORPH board and was vilified and told to shove off and my posts deleted. Their lose , I hold both

[sev22] 03/2/2021 10:37

I think we are only just getting started here with this company.

House Broker says with potentially two Phase 3-ready assets (XF-73 having been awarded both QIDP and Fast Track status by the FDA) for development, licensing and/or co- development by the end of 2021, Destiny starts the year with a risk/reward profile significantly skewed to the upside in our opinion. We leave forecasts unchanged and reiterate our 300p target price, which would rise to c.380p on a positive Phase 2b readout.

[mikeh30] 03/2/2021 10:26

It now got the excitement run up to results. You'll be saying 'why didn't I buy more' next month

[garth] 03/2/2021 10:04

Taken a small initial holding this morning. Would have been nice to have been here a few weeks ago. I feel a little late arriving.

G.

[okidokicoki] 02/2/2021 11:43

Price movement very quiet here last few days . Its either flying up and down or as still as a dew pond

[gb904150] 02/2/2021 08:37

Professor Mark Wilcox looks a fantastic appointment to the scientific advisory board (SAB).

...consultant microbiologist and Head of R&D in Microbiology at the Leeds Teaching Hospitals and is Lead on Clostridium difficile infection for Public Health England (PHE).

[bspgamer] 02/2/2021 07:15

SPOR-COV™ for COVID-19COVID-19 is a new respiratory virus that has caused a major global pandemic. There is an urgent need for new treatments for COVID-19 and related viral infections.SPOR-COV™, a collaboration between Destiny Pharma and SporeGen Limited is a prophylactic approach that targets the innate immune system with potential to develop COVID-19 protection within a few days of treatment.prophylactic approach targets the innate immune system with potential to develop COVID-19 protection within a few days of treatment.The SPOR?COV™ product consists of a proprietary formulation of Bacillus bacteria that will be administered nasally as a spray. SPOR-COV™ has already been shown by SporeGen to provide complete (100%) protection in preclinical models of influenza.SPOR-COV™ is different to vaccines in that it utilises the innate immune system with the aim of developing COVID-19 protection within a few days after dosing. As an "easy to use" first line of defence, it has the potential to reduce COVID-19 infection rates and transmission significantly. The final SPOR-COV™ product is planned to be straightforward to produce at both high volumes and at low cost. Additional attributes are that it can be stockpiled almost indefinitely without the need for cold chain refrigeration as it is a very stable product. It could be made available globally as a cost-effective measure in the fight against COVID-19 as well as new COVID strains and other respiratory viral infections.

[okidokicoki] 01/2/2021 07:44

On a different note people. There seems to be some very knowledgeable people on here . My question will you be taking the vaccine seems normal to me but alot are worried about it .

[supracat] 30/1/2021 07:47

Agreed. Some big partnerships will be the way to go but also liked his idea that they may choose to undertake some regional sales themselves ie exclude certain regions from the partnership deals to give them a margin boost by making the sales directly with a particular region or nation. Counting down the weeks now for the P2b results.

[kipper1960] 28/1/2021 09:14

Yes, very good presentation and Q&A. Neil played down the possibility of a Nasdaq listing , so probably unlikely in 2021. seems that emphasis for rolling out the 2 phase 3 clinicals will be through partnering with pharmas.

[mach100] 27/1/2021 20:51

Timbo were you in VAL too? Please let this be better. Val was run by complete shysters. By contrast the CEO here comes across as a genuine guy.

[sev22] 27/1/2021 19:47

Just let you know that a recording of the presentation: DESTINY PHARMA PLC -

Introduction to Destiny Pharma plc, along with responses to questions that were answered by the company are now available for you to review in the meeting archive.

Please login in to view the recording and Q&A:

View Recording & Q&A.

Should you have any questions, please contact [e-mail].

Kind Regards,

The Team at Investor Meet Company.

[okidokicoki] 27/1/2021 19:45

Anyway to get a copy of this was working and would love to hear what was said .

[timbo003] 27/1/2021 18:13

Thanks for the positive feedback folks, yes it was me (TimG) asking quite a few of the questions.

I bought in at the placing (and have I've bought a few more since) and this was the first time I really had an opportunity to ask any questions (there wasn't really adequate time at the Proactive event last week). I spent 25 years working in Pharmaceutical development for a variety of big pharmas hence the technical nature for some of the questions 🙂

[supracat] 27/1/2021 17:00

Yea. Really good questions from Tim.

[mach100] 27/1/2021 16:20

If it is Tim he certainly knows his stuff. The technical questions were of a high order.

[supracat] 27/1/2021 16:06

Yes. Really good session and well hosted too. Are you the Tim who asked all the questions?? I managed to get two questions raised and felt neil dealt with them pretty well without giving too much confidential info away. Look forward to next session which hopefully will be after a positive P2b announcement.

[timbo003] 27/1/2021 12:55

That was a really good presentation IMO and Neil managed to get through all the questions at the end which was quite an acheivement. The investor meet company format is definitely better than the online Proactive investor seminars for getting over the investment case (largely due to the additional time available), although I do think Proactive excel with their Director interviews and the old one2one physical events in London were extremely useful (but sadly no longer possible).

[timbo003] 27/1/2021 11:43

Neil sounds very much like Chris Packham (winterwatch)